Metabolic inflammation in heart failure with preserved ejection fraction

Inflammation and metabolic disorders

Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · see citing works

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140 · see citing works

Inflamm‐aging: An Evolutionary Perspective on Immunosenescence

FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · see citing works

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191 · see citing works

Succinate is an inflammatory signal that induces IL-1β through HIF-1α

Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · see citing works

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · see citing works

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586 · see citing works

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · see citing works

Obesity and the risk of heart failure

Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093 · see citing works

Spironolactone for heart failure with preserved ejection fraction

Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809 · see citing works

Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis

Antlanger, M., Aschauer, S., Kopecky, C., Hecking, M., Kovarik, J. J., Werzowa, J. M., Mascherbauer, J., Genser, B., Säemann, M. D., & Bonderman, D. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000473868 · Cited by 2,808 · see citing works

Endoplasmic reticulum stress and the inflammatory basis of metabolic disease

Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · see citing works

Forecasting the Impact of Heart Failure in the United States

Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., Ikonomidis, J. S., Khavjou, O., Konstam, M. A., Maddox, T. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/hhf.0b013e318291329a · Cited by 2,802 · see citing works

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655 · see citing works

The Failing Heart — An Engine Out of Fuel

Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,410 · see citing works

Inflammatory links between obesity and metabolic disease

Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · see citing works

Inflammatory mechanisms linking obesity and metabolic disease

Saltiel, A. R., & Olefsky, J. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92035 · Cited by 2,212 · cited 1× · see citing works

Myocardial Fatty Acid Metabolism in Health and Disease

Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,180 · see citing works

Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization

Jha, A. K., Huang, S. C.-C., Sergushichev, A., Lampropoulou, V., Ivanova, Y., Loginicheva, E., Chmielewski, K., Stewart, K. M., Ashall, J., Everts, B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.005 · Cited by 2,066 · see citing works

Myocardial Substrate Metabolism in the Normal and Failing Heart

Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,042 · see citing works

The cellular and signaling networks linking the immune system and metabolism in disease

Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551 · see citing works

Epidemiology of heart failure with preserved ejection fraction

Dunlay, S. M., Roger, V. L., & Redfield, M. M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.65 · Cited by 1,545 · see citing works

Fibrosis–a common pathway to organ injury and failure

Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428 · see citing works

Relationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle

Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,266 · see citing works

α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming

Liu, P.-S., Wang, H., Li, X., Chao, T., Teav, T., Christen, S., Di Conza, G., Cheng, W.-C., Chou, C.-H., Vavakova, M., et al. (2017) · Nature Immunology · doi:10.1038/ni.3796 · Cited by 1,264 · see citing works

Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production

Michelucci, A., Cordes, T., Ghelfi, J., Pailot, A., Reiling, N., Goldmann, O., Binz, T., Wegner, A., Tallam, A., Rausell, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218599110 · Cited by 1,191 · see citing works

Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction

Obokata, M., Reddy, Y. N. V., Pislaru, S. V., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.026807 · Cited by 1,179 · see citing works

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

González-López, E., Gallego‐Delgado, M., Guzzo-Merello, G., Moral, F. J. D. H.-D., Marcos, M. C., Robles, C., Bornstein, B., Salas, C., Lara‐Pezzi, E., Alonso‐Pulpón, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,176 · see citing works

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

Solomon, S. D., Zile, M. R., Pieske, B. M., Voors, A. A., Shah, A. M., Kraigher‐Krainer, E., Shi, V. C., Bransford, T. L., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,171 · see citing works

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G. D., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,156 · see citing works

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Pfeffer, M. A., Claggett, B. L., Assmann, S. F., Boineau, R., Anand, I. S., Clausell, N., Desai, A. S., Díaz, R., Fleg, J. L., Gordeev, I. G., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.013255 · Cited by 1,066 · see citing works

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap

Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003 · see citing works

Nitrosative stress drives heart failure with preserved ejection fraction

Schiattarella, G. G., Altamirano, F. J., Tong, D., French, K. M., Villalobos, E., Kim, S. Y., Luo, X., Jiang, N., May, H. I., Wang, Z. V., et al. (2019) · Nature · doi:10.1038/s41586-019-1100-z · Cited by 956 · see citing works

Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression.

Sessa, W. C., Pritchard, K., Seyedi, N., Wang, J., & Hintze, T. H. (1994) · Circulation Research · doi:10.1161/01.res.74.2.349 · Cited by 934 · cited 1× · see citing works

Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity

Arts, R. J. W., Novakovic, B., ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S.-C., Wang, S.-Y., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.008 · Cited by 930 · see citing works

Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration

Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R. (2019) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005375 · Cited by 860 · see citing works

Environment and Disease Risks

Rappaport, S. M., & Smith, M. T. (2010) · Science · doi:10.1126/science.1192603 · Cited by 850 · see citing works

Heart Failure With Preserved Ejection Fraction In Perspective

Pfeffer, M. A., Shah, A. M., & Borlaug, B. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.313572 · Cited by 843 · see citing works

Targeting cardiac fibrosis with engineered T cells

Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1546-z · Cited by 801 · see citing works

Nitric oxide signalling in cardiovascular health and disease

Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779 · see citing works

Macrophages, Immunity, and Metabolic Disease

McNelis, J., & Olefsky, J. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.010 · Cited by 728 · see citing works

The human heart contains distinct macrophage subsets with divergent origins and functions

Bajpai, G., Schneider, C., Wong, N., Bredemeyer, A., Hulsmans, M., Nahrendorf, M., Epelman, S., Kreisel, D., Liu, Y., Itoh, A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0059-x · Cited by 712 · see citing works

Nitric Oxide and Cardiac Function

Kelly, R. A., Balligand, J., & Smith, T. W. (1996) · Circulation Research · doi:10.1161/01.res.79.3.363 · Cited by 710 · see citing works

Innate Immunity and the Failing Heart

Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 690 · see citing works

Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium

Packer, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.509 · Cited by 656 · cited 1× · see citing works

Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction

Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.931451 · Cited by 644 · see citing works

Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction

Franssen, C., Chen, H. S., Unger, A., Korkmaz, H. I., Keulenaer, G. W. D., Tschöpe, C., Leite-Moreira, A. F., Musters, R. J. P., Niessen, H. W. M., Linke, W. A., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.10.007 · Cited by 601 · see citing works

A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation

Williams, N. C., & O'Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 569 · see citing works

Nitric Oxide and Cardiac Function

Massion, P. B., Féron, O., Dessy, C., & Balligand, J. (2003) · Circulation Research · doi:10.1161/01.res.0000088351.58510.21 · Cited by 566 · see citing works

Obesity, Hypertension, and Cardiac Dysfunction

Mouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020) · Circulation Research · doi:10.1161/circresaha.119.312321 · Cited by 549 · see citing works

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction

Redfield, M. M., Anstrom, K. J., Levine, J. A., Koepp, G. A., Borlaug, B. A., Chen, H. H., LeWinter, M. M., Joseph, S. M., Shah, S. J., Semigran, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510774 · Cited by 547 · see citing works

An acute immune response underlies the benefit of cardiac stem cell therapy

Vagnozzi, R. J., Maillet, M., Sargent, M. A., Khalil, H., Johansen, A. K. Z., Schwanekamp, J. A., York, A. J., Huang, V. H., Nahrendorf, M., Sadayappan, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1802-2 · Cited by 547 · see citing works

Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota

Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Bursi, F., Borlaug, B. A., Ommen, S. R., Kass, D. A., & Redfield, M. M. (2007) · Circulation · doi:10.1161/circulationaha.106.659763 · Cited by 544 · see citing works

Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

van Heerebeek, L., Hamdani, N., Falcão‐Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, G. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 525 · see citing works

Targeting metabolic dysregulation for fibrosis therapy

Zhao, X. L., Kwan, J. Y. Y., Yip, K. W., Liu, P. P., & Liu, F. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 516 · see citing works

Foundations of Immunometabolism and Implications for Metabolic Health and Disease

Hotamışlıgil, G. S. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.009 · Cited by 515 · see citing works

The role of adipose tissue in cardiovascular health and disease

Oikonomou, E. K., & Antoniades, C. A. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0097-6 · Cited by 509 · see citing works

Heart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies

Sharma, K., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.115.302922 · Cited by 508 · see citing works

Cardiac macrophages promote diastolic dysfunction

Hulsmans, M., Sager, H. B., Roh, J. D., Valero‐Muñoz, M., Houstis, N. E., Iwamoto, Y., Sun, Y., Wilson, R. M., Wojtkiewicz, G. R., Tricot, B., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171274 · Cited by 498 · see citing works

Calcium signaling in immune cells

Vig, M., & Kinet, J. (2008) · Nature Immunology · doi:10.1038/ni.f.220 · Cited by 494 · see citing works

Inflammatory Markers and Incident Heart Failure Risk in Older Adults

Kalogeropoulos, A., Georgiopoulou, V., Psaty, B. M., Rodondi, N., Smith, A. L., Harrison, D. G., Liu, Y., Hoffmann, U., Bauer, D. C., Newman, A. B., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.045 · Cited by 478 · see citing works

Exercise Intolerance in Patients With Heart Failure

Del Buono, M. G., Arena, R., Borlaug, B. A., Carbone, S., Canada, J. M., Kirkman, D. L., Garten, R., Rodriguez-Miguelez, P., Guazzi, M., Lavie, C. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.072 · Cited by 477 · see citing works

Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum

Borlaug, B. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.110.954388 · Cited by 451 · see citing works

Krebs cycle Reborn in macrophage immunometabolism

Ryan, D. G., & O'Neill, L. A. J. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-081619-104850 · Cited by 444 · see citing works

Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction

Shah, A. M., Shah, S. J., Anand, I. S., Sweitzer, N. K., O’Meara, E., Heitner, J. F., Sopko, G. S., Li, G., Assmann, S. F., McKinlay, S. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000887 · Cited by 437 · see citing works

Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary

Shah, S. J., Borlaug, B. A., Kitzman, D. W., McCulloch, A. D., Blaxall, B. C., Agarwal, R., Chirinos, J. A., Collins, S., Deo, R. C., Gladwin, M. T., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041886 · Cited by 436 · see citing works

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction

Cohen, J. B., Schrauben, S. J., Zhao, L., Basso, M. D., Cvijic, M. E., Li, Z., Yarde, M., Wang, Z., Bhattacharya, P. T., Chirinos, D. A., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.09.009 · Cited by 432 · see citing works

Relationship between physical activity, body mass index, and risk of heart failure

Pandey, A., LaMonte, M., Klein, L., Ayers, C., Psaty, B. M., Eaton, C. B., Allen, N. B., de Lemos, J. A., Carnethon, M., Greenland, P., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.081 · Cited by 398 · see citing works

Relation Between Work and Phosphate Metabolite in the in Vivo Paced Mammalian Heart

Balaban, R. S., Kantor, H. L., Katz, L. A., & Briggs, R. W. (1986) · Science · doi:10.1126/science.3704638 · Cited by 395 · see citing works

Krebs Cycle Reimagined: The Emerging Roles of Succinate and Itaconate as Signal Transducers

Murphy, M. P., & O'Neill, L. A. J. (2018) · Cell · doi:10.1016/j.cell.2018.07.030 · Cited by 393 · see citing works

Energy metabolism of the heart: From basic concepts to clinical applications applications

Taegtmeyer, H. (1994) · Current Problems in Cardiology · doi:10.1016/0146-2806(94)90008-6 · Cited by 391 · see citing works

Evolution of Inflammatory Diseases

Okin, D. A., & Medzhitov, R. M. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.029 · Cited by 390 · see citing works

Metabolic Coordination of Physiological and Pathological Cardiac Remodeling

Gibb, A., & Hill, B. G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312017 · Cited by 381 · see citing works

Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction

Zakeri, R., Chamberlain, A. M., Roger, V. L., & Redfield, M. M. (2013) · Circulation · doi:10.1161/circulationaha.113.001475 · Cited by 370 · see citing works

The metabolic ER stress sensor IRE1α suppresses alternative activation of macrophages and impairs energy expenditure in obesity

Shan, B., Wang, X., Wu, Y., Xu, C., Xia, Z., Dai, J., Shao, M., Zhao, F., He, S., Yang, L., et al. (2017) · Nature Immunology · doi:10.1038/ni.3709 · Cited by 367 · see citing works

Heart failure with preserved ejection fraction: from mechanisms to therapies

Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355 · see citing works

Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease

Liberale, L., Montecucco, F., Tardif, J., Libby, P., & Camici, G. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz961 · Cited by 347 · see citing works

The metabolic regulation of aging

Finkel, T. (2015) · Nature Medicine · doi:10.1038/nm.3998 · Cited by 325 · see citing works

Regulation of Energy Metabolism of the Heart during Acute Increase in Heart Work

Goodwin, G. W., Taylor, C. S., & Taegtmeyer, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29530 · Cited by 323 · see citing works

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction

Tromp, J., Westenbrink, B. D., Ouwerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P. P., Metra, M., Anker, S. D., Cleland, J. G. F., Dickstein, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.050 · Cited by 307 · see citing works

Cardiac Energy Metabolism in Obesity

Lopaschuk, G. D., Folmes, C. D. L., & Stanley, W. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.150417 · Cited by 302 · see citing works

Malonyl-CoA, a Key Signaling Molecule in Mammalian Cells

Saggerson, D. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155434 · Cited by 301 · see citing works

Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction

Kumar, A. A., Kelly, D. P., & Chirinos, J. A. (2019) · Circulation · doi:10.1161/circulationaha.118.036259 · Cited by 297 · see citing works

Assessing Cardiac Metabolism

Taegtmeyer, H., Young, M. E., Lopaschuk, G. D., Abel, E. D., Brunengraber, H., Darley-Usmar, V. M., Rosiers, C. D., Gerszten, R. E., Glatz, J. F. C., Griffin, J. L., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000097 · Cited by 283 · see citing works

Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study)

Tassell, B. W. V., Arena, R. A., Biondi‐Zoccai, G., Canada, J. M., Oddi, C., Abouzaki, N. A., Jahangiri, A., Falcao, R. A., Kontos, M. C., Shah, K. B., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.047 · Cited by 280 · see citing works

S-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt

Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B. C., de Oliveira, M. G., Velloso, L. A., Curi, R., & Saad, M. J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.4.959 · Cited by 277 · see citing works

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

de Denus, S., O’Meara, E., Desai, A. S., Claggett, B. L., Lewis, E. F., Leclair, G., Jutras, M., Lavoie, J., Solomon, S. D., Pitt, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1612601 · Cited by 274 · see citing works

ATP-citrate lyase is essential for macrophage inflammatory response

Infantino, V., Iacobazzi, V., Palmieri, F., & Menga, A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.037 · Cited by 269 · see citing works

Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation

Bailey, J. D., Diotallevi, M., NICOL, T., McNeill, E., Shaw, A., Chuaiphichai, S., Hale, A., Starr, A., Nandi, M., Stylianou, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.018 · Cited by 266 · see citing works

Myocardial substrate metabolism influences left ventricular energetics in vivo

Korvald, C., Elvenes, O. P., & Myrmel, T. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.4.h1345 · Cited by 264 · see citing works

Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications

Pollack, R. M., Donath, M. Y., LeRoith, D., & Leibowitz, G. (2016) · Diabetes Care · doi:10.2337/dcs15-3015 · Cited by 261 · see citing works

Circulating Biomarkers of Distinct Pathophysiological Pathways in Heart Failure with Preserved vs. Reduced Left Ventricular Ejection Fraction

Wijk, S. S., van Empel, V. P. M., Davarzani, N., Maeder, M. T., Handschin, R., Pfisterer, M. E., Rocca, H. B., & for the TIME-CHF investigators (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.414 · Cited by 258 · see citing works

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Bonderman, D., Pretsch, I., Steringer‐Mascherbauer, R., Jansa, P., Rosenkranz, S., Tufaro, C., Bojic, A., Lam, C. S. P., Frey, R., Kilama, M. O., et al. (2014) · CHEST Journal · doi:10.1378/chest.14-0106 · Cited by 258 · see citing works

Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction

Shah, A. M., Claggett, B. L., Sweitzer, N. K., Shah, S. J., Anand, I. S., O’Meara, E., Desai, A. S., Heitner, J. F., Li, G., Fang, J. C.-T., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001583 · Cited by 257 · see citing works

Inflammageing and metaflammation: The yin and yang of type 2 diabetes

Prattichizzo, F., Nigris, V. D., Spiga, R., Mancuso, E., Sala, L. L., Antonicelli, R., Testa, R., Procopio, A. D., Olivieri, F., & Ceriello, A. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.003 · Cited by 249 · see citing works

Linking Gene Expression to Function: Metabolic Flexibility in the Normal and Diseased Heart

Taegtmeyer, H., Golfman, L. S., Sharma, S., Razeghi, P., & Arsdall, M. R. V. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1302.017 · Cited by 245 · see citing works

An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy

Frati, G., Schirone, L., Chimenti, I., Yee, D., Biondi‐Zoccai, G., Volpe, M., & Sciarretta, S. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx011 · Cited by 245 · see citing works

Effects of moderate hypertension on cardiac function and metabolism in the rabbit.

Taegtmeyer, H., & Overturf, M. L. (1988) · Hypertension · doi:10.1161/01.hyp.11.5.416 · Cited by 241 · see citing works

S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction

Yang, L., Calay, E. S., Fan, J., Arduini, A., Kunz, R. C., Gygi, S. P., Yalçın, A., Fu, S., & Hotamışlıgil, G. S. (2015) · Science · doi:10.1126/science.aaa0079 · Cited by 229 · see citing works

iNOS as a metabolic enzyme under stress conditions

Anavi, S., & Tirosh, O. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.10.411 · Cited by 226 · see citing works

Growth Differentiation Factor 15, ST2, High-Sensitivity Troponin T, and N-Terminal Pro Brain Natriuretic Peptide in Heart Failure with Preserved vs. Reduced Ejection Fraction

Santhanakrishnan, R., Chong, J. P. C., Ng, T. P., Ling, L. H., Sim, D., Leong, K. T. G., Yeo, P. S. D., Ong, H. Y., Jaufeerally, F. R., Wong, R. C.-C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs130 · Cited by 217 · see citing works

IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction

Tassell, B. W. V., Trankle, C. R., Canada, J. M., Carbone, S., Buckley, L. F., Kadariya, D., Buono, M. G. D., Billingsley, H., Wohlford, G. F., Viscusi, M. M., et al. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005036 · Cited by 214 · see citing works

Malonylation of GAPDH is an inflammatory signal in macrophages

Galván-Peña, S., Carroll, R. G., Newman, C. F., Hinchy, E. C., Pålsson‐McDermott, E. M., Robinson, E. K., Covarrubias, S., Nadin, A. J., James, A. M., Haneklaus, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08187-6 · Cited by 213 · see citing works

Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction

Burke, M. A., Katz, D. H., Beussink‐Nelson, L., Selvaraj, S., Gupta, D. K., Fox, J. M., Chakrabarti, S., Sauer, A. J., Rich, J. D., Freed, B. H., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000854 · Cited by 208 · see citing works

Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction

Pandey, A., Patel, K. V., Vaduganathan, M., Sarma, S., Haykowsky, M. J., Berry, J. D., & Lavie, C. J. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.09.006 · Cited by 201 · see citing works

Heart failure with preserved ejection fraction: a clinical dilemma

Michel Komajda, N., & Lam, C. S. P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu067 · Cited by 198 · see citing works

Cytokine-like Roles for Metabolites in Immunity

Zasłona, Z., & O'Neill, L. A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.002 · Cited by 198 · see citing works

Mitochondrial calcium and the regulation of metabolism in the heart

Williams, G. S. B., Boyman, L., & Lederer, W. J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.019 · Cited by 194 · see citing works

The Cellular and Molecular Basis of Translational Immunometabolism

Norata, G. D., Caligiuri, G., Chavakis, T., Matarese, G., Netea, M. G., Nicoletti, A., O'Neill, L. A. J., & Marelli‐Berg, F. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.023 · Cited by 193 · see citing works

The immunomodulating role of exercise in metabolic disease

Lancaster, G. I., & Febbraio, M. A. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.008 · Cited by 193 · see citing works

A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation

Infantino, V., Iacobazzi, V., Menga, A., Avantaggiati, M. L., & Palmieri, F. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.013 · Cited by 191 · see citing works

Endoplasmic Reticulum Stress Activates Unfolded Protein Response Signaling and Mediates Inflammation, Obesity, and Cardiac Dysfunction: Therapeutic and Molecular Approach

Amen, O. M., Sarker, S. D., Ghildyal, R., & Arya, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00977 · Cited by 190 · see citing works

The p65 subunit of NF-κB binds to PGC-1α, linking inflammation and metabolic disturbances in cardiac cells

Álvarez-Guardia, D., Palomer, X., Coll, T., Davidson, M. M., Chan, T. O., Feldman, A. M., Laguna, J. C., & Vázquez‐Carrera, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq080 · Cited by 187 · see citing works

Mechanical Unloading in Heart Failure

Uriel, N. Y., SAYER, G. T., Annamalai, S., Kapur, N. K., & Burkhoff, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.038 · Cited by 186 · see citing works

Heart Failure With Preserved Ejection Fraction

Loffredo, F. S., Nikolova, A., Pancoast, J. R., & Lee, R. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.302929 · Cited by 181 · see citing works

TNF-α reduces PGC-1α expression through NF-κB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model

Palomer, X., Álvarez-Guardia, D., Rodríguez‐Calvo, R., Coll, T., Laguna, J. C., Davidson, M. M., Chan, T. O., Feldman, A. M., & Vázquez‐Carrera, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn327 · Cited by 178 · see citing works

Target-Selective Protein S-Nitrosylation by Sequence Motif Recognition

Jia, J., Arif, A., Terenzi, F., Willard, B. B., Plow, E. F., Hazen, S. L., & Fox, P. L. (2014) · Cell · doi:10.1016/j.cell.2014.09.032 · Cited by 176 · see citing works

Pentraxin 3 Is a New Inflammatory Marker Correlated With Left Ventricular Diastolic Dysfunction and Heart Failure With Normal Ejection Fraction

Matsubara, J., Sugiyama, S., Nozaki, T., Sugamura, K., Konishi, M., Ohba, K., Matsuzawa, Y., Akiyama, E., Yamamoto, E., Sakamoto, K., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.018 · Cited by 175 · see citing works

The “Muscle Hypothesis” of Chronic Heart Failure

Coats, A. J. S. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0218 · Cited by 166 · see citing works

The evolution of metabolic cycles

Baldwin, J. E., & Krebs, H. (1981) · Nature · doi:10.1038/291381a0 · Cited by 165 · see citing works

The Role of Exercise in Cardiac Aging

Roh, J. D., Rhee, J., Chaudhari, V., & Rosenzweig, A. (2016) · Circulation Research · doi:10.1161/circresaha.115.305250 · Cited by 160 · see citing works

Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the Heart

Ko, H. J., Zhang, Z., Jung, D. Y., Jun, J. Y., Ma, Z., Jones, K. E., Chan, S. Y., & Kim, J. K. (2009) · Diabetes · doi:10.2337/db08-1361 · Cited by 157 · see citing works

Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease Pathogenesis

Glezeva, N., Voon, V., Watson, C. J., Horgan, S. J., McDonald, K., Ledwidge, M. T., & Baugh, J. A. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.11.004 · Cited by 152 · see citing works

Left Atrium in Heart Failure With Preserved Ejection Fraction

Rossi, A., Gheorghiade, M., Triposkiadis, F. K., Solomon, S. D., Pieske, B. M., & Butler, J. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001276 · Cited by 144 · see citing works

High-sensitivity C-reactive protein in heart failure with preserved ejection fraction

DuBrock, H. M., AbouEzzeddine, O. F., & Redfield, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201836 · Cited by 144 · see citing works

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction

D’Amario, D., Migliaro, S., Borovac, J. A., Restivo, A., Vergallo, R., Galli, M., Leone, A. M., Montone, R. A., Niccoli, G., Aspromonte, N., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01347 · Cited by 135 · see citing works

Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production

Wang, B., Rao, Y.-H., Inoue, M., Hao, R., Lai, C.-H., Chen, D. J., McDonald, S. L., Choi, M.-C., Wang, Q., Shinohara, M. L., et al. (2014) · Nature Communications · doi:10.1038/ncomms4479 · Cited by 127 · see citing works

Biomarkers of Heart Failure with Normal Ejection Fraction: A Systematic Review

Cheng, J. M., Akkerhuis, K. M., Battes, L. C., van Vark, L. C., Hillege, H. L., Paulus, W. J., Boersma, E. H., & Kardys, I. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft106 · Cited by 121 · see citing works

Switches in cardiac muscle gene expression as a result of pressure and volume overload

Schwartz, K., Boheler, K. R., Bastie, D. D. L., et al. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.3.r364 · Cited by 118 · see citing works

Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction

Dalos, D., Mascherbauer, J., Zotter‐Tufaro, C., Duca, F., Kammerlander, A. A., Aschauer, S., & Bonderman, D. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.052 · Cited by 111 · see citing works

Association between Use of Statins and Mortality in Patients with Heart Failure and Ejection Fraction of ≥50%

Alehagen, U., Benson, L., Edner, M., Dahlström, U., & Lund, L. H. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002143 · Cited by 109 · see citing works

On Getting There from Here

McKnight, S. L. (2010) · Science · doi:10.1126/science.1199908 · Cited by 108 · see citing works

Role of Biomarkers in Cardiac Structure Phenotyping in Heart Failure with Preserved Ejection Fraction: Critical Appraisal and Practical Use

D’Elia, E., Vaduganathan, M., Gori, M., Gavazzi, A., Butler, J., & Senni, M. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.430 · Cited by 107 · see citing works

Macrophages in Heart Failure with Reduced versus Preserved Ejection Fraction

DeBerge, M., Shah, S. J., Wilsbacher, L. D., & Thorp, E. B. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.002 · Cited by 107 · see citing works

Why Don’t We Have Proven Treatments for HFpEF?

Roh, J. D., Houstis, N. E., & Rosenzweig, A. (2017) · Circulation Research · doi:10.1161/circresaha.116.310119 · Cited by 106 · see citing works

Can Exercise Teach Us How to Treat Heart Disease?

Mann, N., & Rosenzweig, A. (2012) · Circulation · doi:10.1161/circulationaha.111.060376 · Cited by 105 · see citing works

An Integrative Translational Approach to Study Heart Failure with Preserved Ejection Fraction: A Position Paper from the Working Group on Myocardial Function of the European Society of Cardiology

Lourenço, A. P., Leite-Moreira, A. F., Balligand, J., Bauersachs, J. K., Dawson, D. K., de Boer, R. A., Windt, L. J. D., Falcão‐Pires, I., Fontes‐Carvalho, R., Franz, S., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1059 · Cited by 105 · see citing works

Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome

Sciarretta, S., Ferrucci, A., Ciavarella, G. M., DEPAOLIS, P., Venturelli, V., Tocci, G., Biase, L. D., Rubattu, S., & Volpe, M. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.01.023 · Cited by 104 · see citing works

New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes. Implication for exercise in obesity.

Mazur-Biały, A. I., Bilski, J., Pocheć, E., et al. (2017) · PubMed · Cited by 98 · see citing works

Control of Inflammation by Calorie Restriction Mimetics: On the Crossroad of Autophagy and Mitochondria

Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 96 · see citing works

Metabolic Changes in Spontaneously Hypertensive Rat Hearts Precede Cardiac Dysfunction and Left Ventricular Hypertrophy

Li, J., Kemp, B. A., Howell, N. L., Massey, J. C., Mińczuk, K., Huang, Q., Chordia, M. D., Roy, R., Patrie, J. T., Davogustto, G., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010926 · Cited by 90 · see citing works

Obese Heart Failure With Preserved Ejection Fraction Phenotype

Kitzman, D. W., & Lam, C. S. P. (2017) · Circulation · doi:10.1161/circulationaha.117.028365 · Cited by 87 · see citing works

The many faces of heart failure with preserved ejection fraction

Shah, A. M., & Pfeffer, M. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.123 · Cited by 83 · see citing works

Defining the Human Envirome

Riggs, D. W., Yeager, R. A., & Bhatnagar, A. (2018) · Circulation Research · doi:10.1161/circresaha.117.311230 · Cited by 82 · see citing works

Unfolding Discoveries in Heart Failure

Paulus, W. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr1913825 · Cited by 80 · see citing works

Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk‐related rat model of heart failure with preserved ejection fraction

Miranda‐Silva, D., Wüst, R. C. I., Conceição, G., Gonçalves‐Rodrigues, P., Gonçalves, N., Gonçalves, A., Kuster, D. W. D., Leite-Moreira, A. F., van der Velden, J., Beleza, J., et al. (2019) · Acta Physiologica · doi:10.1111/apha.13378 · Cited by 77 · see citing works

Ventricular Remodeling in Heart Failure with Preserved Ejection Fraction

Shah, A. M. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0166-4 · Cited by 74 · see citing works

Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence

Aimo, A., Cerbai, E., Bartolucci, G., Adamo, L., Barison, A., Surdo, G. L., Biagini, S., Passino, C., & Emdin, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104694 · Cited by 74 · see citing works

Nitric oxide controls cardiac substrate utilization in the conscious dog

Recchia, F. A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00245-x · Cited by 73 · see citing works

Targeted Disruption of Inducible Nitric Oxide Synthase Protects Against Aging, S-Nitrosation, and Insulin Resistance in Muscle of Male Mice

Ropelle, E. R., Pauli, J. R., Cintra, D. E., da Silva, A. S. R., de Souza, C. T., Guadagnini, D., Carvalho, B. M., Caricilli, A. M., Katashima, C. K., Filho, C., et al. (2012) · Diabetes · doi:10.2337/db12-0339 · Cited by 73 · see citing works

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction

Abernethy, A. D., Raza, S. S., Sun, J., Anstrom, K. J., Tracy, R. P., Steiner, J., VanBuren, P., & LeWinter, M. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007385 · Cited by 67 · see citing works

Do Most Patients with Obesity or Type 2 Diabetes, and Atrial Fibrillation, Also have Undiagnosed Heart Failure? A Critical Conceptual Framework for Understanding Mechanisms and Improving Diagnosis and Treatment

Packer, M. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1646 · Cited by 63 · see citing works

Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial

Lewis, G. A., Schelbert, E. B., Naish, J. H., Bedson, E., Dodd, S. R., Eccleson, H., Clayton, D., Duran-Jimenez, B., McDonagh, T. A., Williams, S. G., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06876-y · Cited by 62 · see citing works

Role of Physical Training in Heart Failure with Preserved Ejection Fraction

Haykowsky, M. J., Brubaker, P. H., & Kitzman, D. W. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0087-7 · Cited by 61 · see citing works

Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs

Recchia, F. A., Osorio, J. C., Chandler, M. P., Xu, X., Panchal, A. R., Lopaschuk, G. D., Hintze, T. H., & Stanley, W. C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e197 · Cited by 58 · see citing works

Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease ― Report From the JASPER Study ―

Marume, K., Takashio, S., Nagai, T., Tsujita, K., Saito, Y., Yoshikawa, T., & Anzai, T. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0639 · Cited by 50 · see citing works

Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species

White, P. J., Charbonneau, A., Cooney, G. J., & Marette, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2010 · Cited by 49 · see citing works

Treating Heart Failure with Preserved Ejection Fraction: Learning from Pulmonary Fibrosis

Graziani, F., Varone, F., Crea, F., & Richeldi, L. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1286 · Cited by 43 · see citing works

Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study

Silvestrini, A., Bruno, C., Vergani, E., Venuti, A., Favuzzi, A. M. R., Guidi, F., Nicolotti, N., Meucci, E., Mordente, A., & Mancini, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210320 · Cited by 43 · see citing works

An “Exercise” in Cardiac Metabolism

Kolwicz, S. C. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00066 · Cited by 41 · see citing works

Inhibition of myocardial glucose uptake by cGMP

Depré, C., Gaussin, V., Ponchaut, S., Fischer, Y., Vanoverschelde, J., & Hue, L. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1443 · Cited by 37 · see citing works

Nitric oxide modulates cardiac contractility and oxygen consumption without changing contractile efficiency

Suto, N., Mikuniya, A., Okubo, T., et al. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.1.h41 · Cited by 36 · see citing works

Bariatric surgery to unload the stressed heart: a metabolic hypothesis

Algahim, M. F., Sen, S., & Taegtmeyer, H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00626.2011 · Cited by 36 · see citing works

De-Meaning of Metabolism

Lazar, M. A., & Birnbaum, M. J. (2012) · Science · doi:10.1126/science.1221834 · Cited by 35 · see citing works

Immunometabolic cross-talk in the inflamed heart

Marelli‐Berg, F. M., & Aksentijević, D. (2019) · Cell Stress · doi:10.15698/cst2019.08.194 · Cited by 34 · see citing works

Protein Thiol Modification of Glyceraldehyde-3-phosphate Dehydrogenase and Caspase-3 by Nitric Oxide

Brüne, B., & Mohr, S. (2001) · Current Protein and Peptide Science · doi:10.2174/1389203013381206 · Cited by 32 · see citing works

Lumpers and splitters: the bumpy road to precision medicine

Lüscher, T. F. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz644 · Cited by 27 · see citing works

A metabolic strategy to reverse fibrosis?

Rabinowitz, J. D., & Mutlu, G. M. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0013-8 · Cited by 25 · see citing works

Strategies of Unloading the Failing Heart from Metabolic Stress

Koutroumpakis, E., Jozwik, B., Aguilar, D. A., & Taegtmeyer, H. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.08.035 · Cited by 24 · see citing works

Sodium‐glucose co‐transporter inhibitors: Medications that mimic fasting for cardiovascular prevention

Giaccari, A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13814 · Cited by 21 · see citing works

Role of Nitric Oxide in the Regulation of Substrate Metabolism in Heart Failure

Recchia, F. A. (2002) · Heart Failure Reviews · doi:10.1023/a:1015324508556 · Cited by 19 · see citing works

Can HFpEF and HFrEF Coexist?

Schiattarella, G. G., Tong, D., & Hill, J. A. (2020) · Circulation · doi:10.1161/circulationaha.119.045171 · Cited by 18 · see citing works

Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs

d’Agostino, C., Labinskyy, V., Lionetti, V., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00745.2005 · Cited by 11 · see citing works

Teasing the Immune System to Repair the Heart

Epstein, J. A., Rosenthal, N. A., & Feldman, A. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr2002014 · Cited by 9 · see citing works

Physical Activity in Heart Failure With Preserved Ejection Fraction

Pandey, A., & Berry, J. D. (2017) · Circulation · doi:10.1161/circulationaha.117.029935 · Cited by 6 · see citing works

When the CAR Targets Scar

Hill, J. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmcibr1912586 · Cited by 4 · see citing works

Reflections of the Editor-in-Chief

Hill, J. A. (2017) · Circulation · doi:10.1161/circulationaha.117.030459 · Cited by 3 · see citing works

Heart Failure With Preserved Ejection Fraction

Borlaug, B. A., Sharma, K., Shah, S. J., & Ho, J. E. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.049 · Cited by 742 · see citing works

Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

Borlaug, B. A., Jensen, M. D., Kitzman, D. W., Lam, C. S. P., Obokata, M., & Rider, O. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac120 · Cited by 450 · see citing works

The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF

Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74 · see citing works

An interferon gamma response signature links myocardial aging and immunosenescence

Ashour, D., Rebs, S., Arampatzi, P., Saliba, A.-E., Dudek, J., Schulz, R., Hofmann, U., Frantz, S., Cochain, C., Streckfuß-Bömeke, K., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad068 · Cited by 39 · see citing works

Obesity/cardiometabolic phenotype of heart failure with preserved ejection fraction: mechanisms to recent trials

Verma, R., Dhingra, N. K., & Connelly, K. A. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001113 · Cited by 24 · see citing works

Discussion on pathogenesis levels of hypertension

Wang, Q. (2007) · Zhongyi-yao xuebao

Death, mode of death, morbidity and requirement for rehospitalization during 2 years after coronary artery bypass grafting in relation to preoperative ejection fraction

Herlitz, J. D., Brandrup, G., Caidahl, K., et al. (1996) · Coronary Artery Disease · doi:10.1097/00019501-199611000-00003 · Cited by 9 · see citing works

Changes in Left Ventricular Ejection Fraction (LVEF) Predict Mortality in Heart Failure Patients With Reduced Ejection Fraction

Kearney, R. E., Williamson, A., Chowdhury, E., et al. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2023.06.054

Prognostic implications of late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy: a longitudinal study of left ventricular function

Nabeta, T., Ishii, S., Ikeda, Y., et al. (2020) · European Heart Journal · doi:10.1093/ehjci/ehaa946.0893

Left Ventricular Ejection Fraction Recovery, Remission, and Relapse in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Center Longitudinal Experience

Bhat, P., Li, L., Ji, X., et al. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.09.044